The findings add to concerns that GLP-1s could take a bite out of the bottom lines of some of the biggest restaurant companies and packaged food makers.
Not in the US, but production is limited and there have been pretty bad shortages in Canada and Australia. They had to put an export ban on Ozempic because so much of it was being sold to Americans, in Canada we pay $160US, while the same box sells for $970US in the states.
Im a diabetic, and earlier in the year we had a hard time getting it due to all the off label use.
Not in the US, but production is limited and there have been pretty bad shortages in Canada and Australia. They had to put an export ban on Ozempic because so much of it was being sold to Americans, in Canada we pay $160US, while the same box sells for $970US in the states.
Im a diabetic, and earlier in the year we had a hard time getting it due to all the off label use.
Thank you for that context.